22(top 2%)
papers
309(top 5%)
citations
8(top 5%)
h-index
11(top 5%)
g-index
22
all documents
342
doc citations
175
citing journals

Top Articles

#TitleJournalYearCitations
1RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung CancersPLoS ONE2016140
2High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancersScientific Reports201888
3Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancerInternational Journal of Oncology202033
4Prognostic value of IL-34 in colorectal cancer patientsImmunological Medicine201917
5Interleukin-34 expression in ovarian cancer: a possible correlation with disease progressionInternational Immunology202017
6A Systematic Approach to the Development of Novel Therapeutics for Lung Cancer Using Genomic AnalysesClinical Pharmacology and Therapeutics201314
7Sox9 regulates the luminal stem/progenitor cell properties of salivary glandsExperimental Cell Research201913
8Biphasic prognostic significance of PD-L1 expression status in patients with early- and locally advanced-stage non-small cell lung cancerCancer Immunology, Immunotherapy202110
9Holliday junction recognition protein as a prognostic biomarker and therapeutic target for oral cancerInternational Journal of Oncology20225
10Characterization of Opa interacting protein 5 as a new biomarker and therapeutic target for oral cancerInternational Journal of Oncology20224
11Oncogenic epidermal growth factor receptor signal-induced histone deacetylation suppresses chemokine gene expression in human lung adenocarcinomaScientific Reports20231
12Development of Therapeutic Cancer Peptide Vaccines for Lung CancerAnnals of Oncology20130
13Characterization of LASEP1 as a new serological and prognostic biomarker and a therapeutic target for lung cancerAnnals of Oncology20150
14Development of therapeutic cancer vaccines and future prospects towards personalized medicineAnnals of Oncology20150
15Identification of candidate lung cancer neoantignes by next generation sequencing towards precision medicineAnnals of Oncology20170
16Characterization of URST1 as a biomarker and therapeutic target for lung cancer and oral cancerAnnals of Oncology20180
17MO18-2 Characterization of URST5 as a potential biomarker and therapeutic target for oral cancerAnnals of Oncology20210
18Development of personalized cancer immunotherapy by integrated genomics.Journal of Clinical Oncology20160
19Characterization of URST1 as a prognostic biomarker and therapeutic target for lung and oral cancers.Journal of Clinical Oncology20170
20Integrated genomics-based discovery of new druggable kinases as a therapeutic target and cancer biomarker for lung cancer.Journal of Clinical Oncology20170
21Identification of URST1 as a prognostic biomarker and therapeutic target for lung cancer.Journal of Clinical Oncology20180
22Peritoneal liquid biopsy used to predict cancer recurrence after gastrointestinal cancer surgery.Journal of Clinical Oncology20180